Achmea Investment Management B.V. Has $26.25 Million Stock Position in The Cigna Group (NYSE:CI)

Achmea Investment Management B.V. lifted its holdings in shares of The Cigna Group (NYSE:CI) by 39.1% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 79,410 shares of the health services provider’s stock after purchasing an additional 22,306 shares during the period. Achmea Investment Management B.V.’s holdings in The Cigna Group were worth $26,250,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of CI. Silicon Valley Capital Partners raised its position in shares of The Cigna Group by 100.0% during the first quarter. Silicon Valley Capital Partners now owns 70 shares of the health services provider’s stock worth $25,000 after purchasing an additional 35 shares during the period. Cedar Wealth Management LLC purchased a new stake in The Cigna Group in the 1st quarter valued at $29,000. Raleigh Capital Management Inc. boosted its holdings in The Cigna Group by 69.5% during the fourth quarter. Raleigh Capital Management Inc. now owns 100 shares of the health services provider’s stock worth $30,000 after purchasing an additional 41 shares during the last quarter. TruNorth Capital Management LLC bought a new position in shares of The Cigna Group in the second quarter valued at approximately $33,000. Finally, Pineridge Advisors LLC purchased a new stake in shares of The Cigna Group during the 4th quarter valued at $37,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

The Cigna Group Price Performance

CI stock opened at $357.44 on Thursday. The firm has a 50 day simple moving average of $342.53 and a two-hundred day simple moving average of $343.92. The stock has a market cap of $101.54 billion, a PE ratio of 29.35, a P/E/G ratio of 1.08 and a beta of 0.50. The Cigna Group has a one year low of $253.95 and a one year high of $370.64. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.71 and a quick ratio of 0.71.

The Cigna Group (NYSE:CI) last announced its earnings results on Thursday, August 1st. The health services provider reported $6.72 earnings per share (EPS) for the quarter, topping the consensus estimate of $6.42 by $0.30. The Cigna Group had a net margin of 1.70% and a return on equity of 17.83%. The company had revenue of $60.52 billion during the quarter, compared to analyst estimates of $58.30 billion. During the same period in the previous year, the business earned $6.13 earnings per share. The firm’s quarterly revenue was up 24.6% compared to the same quarter last year. On average, analysts predict that The Cigna Group will post 28.48 EPS for the current fiscal year.

The Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, September 19th. Investors of record on Wednesday, September 4th will be issued a dividend of $1.40 per share. The ex-dividend date of this dividend is Wednesday, September 4th. This represents a $5.60 dividend on an annualized basis and a dividend yield of 1.57%. The Cigna Group’s dividend payout ratio is 45.98%.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Stephens reaffirmed an “overweight” rating and issued a $410.00 price target on shares of The Cigna Group in a report on Friday, August 2nd. JPMorgan Chase & Co. increased their target price on The Cigna Group from $435.00 to $438.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 21st. Royal Bank of Canada reiterated an “outperform” rating and issued a $384.00 price target on shares of The Cigna Group in a research report on Monday. Baird R W upgraded The Cigna Group to a “strong-buy” rating in a research note on Thursday, May 30th. Finally, Robert W. Baird initiated coverage on The Cigna Group in a research note on Thursday, May 30th. They issued an “outperform” rating and a $388.00 target price for the company. One equities research analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $387.00.

Insider Activity at The Cigna Group

In other The Cigna Group news, Director Elder Granger sold 547 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The stock was sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the sale, the director now owns 5,471 shares of the company’s stock, valued at $1,812,979.98. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, insider Brian C. Evanko sold 4,795 shares of the firm’s stock in a transaction dated Monday, June 24th. The stock was sold at an average price of $345.01, for a total transaction of $1,654,322.95. Following the transaction, the insider now directly owns 39,923 shares of the company’s stock, valued at $13,773,834.23. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Elder Granger sold 547 shares of the business’s stock in a transaction dated Monday, June 17th. The shares were sold at an average price of $331.38, for a total value of $181,264.86. Following the completion of the sale, the director now directly owns 5,471 shares of the company’s stock, valued at approximately $1,812,979.98. The disclosure for this sale can be found here. In the last three months, insiders have sold 8,033 shares of company stock valued at $2,757,740. Corporate insiders own 0.60% of the company’s stock.

The Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.